Page 232 - Vitamin D and Cancer

9 Molecular Biology of Vitamin D Metabolism and Skin Cancer 219

142. Shaulian E, Schreiber M, Piu F et al (2000) The mammalian UV response: c-Jun induction
is required for exit from p53-imposed growth arrest. Cell 103(6):897–907
143. Sinclair C (2006) Risks and benefits of sun exposure: implications for public health practice
based on the Australian experience. Prog Biophys Mol Biol 92(1):173–178
144. Smith ML, Chen IT, Zhan Q et al (1995) Involvement of the p53 tumor suppressor in repair
of u.v.-type DNA damage. Oncogene 10(6):1053–1059
145. Sollitto RB, Kraemer KH, DiGiovanna JJ (1997) Normal vitamin D levels can be maintained
despite rigorous photoprotection: six years’ experience with xeroderma pigmentosum. J Am
Acad Dermatol 37(6):942–947
146. Spencer JM, Kahn SM, Jiang W et al (1995) Activated ras genes occur in human actinic kera-
toses, premalignant precursors to squamous cell carcinomas. Arch Dermatol 131(7):796–800
147. St-Arnaud R (2008) The direct role of vitamin D on bone homeostasis. Arch Biochem
Biophys 473(2):225–230
148. Struhl K, Moqtaderi Z (1998) The TAFs in the HAT. Cell 94(1):1–4
149. Stumpf WE, Sar M, Reid FA et al (1979) Target cells for 1, 25-dihydroxyvitamin D3 in intes-
tinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science 206(4423):1188–1190
150. Su MJ, Bikle DD, Mancianti ML et al (1994) 1, 25-Dihydroxyvitamin D3 potentiates the
keratinocyte response to calcium. J Biol Chem 269(20):14723–14729
151. Suzuki T, Inukai M (2006) Effects of nitrite and nitrate on DNA damage induced by ultravio-
let light. Chem Res Toxicol 19(3):457–462
152. Tagami T, Lutz WH, Kumar R et al (1998) The interaction of the vitamin D receptor with nuclear
receptor corepressors and coactivators. Biochem Biophys Res Commun 253(2):358–363
153. Taylor JA, Hirvonen A, Watson M et al (1996) Association of prostate cancer with vitamin
D receptor gene polymorphism. Cancer Res 56(18):4108–4110
154. Turunen MM, Dunlop TW, Carlberg C et al (2007) Selective use of multiple vitamin D
response elements underlies the 1 alpha, 25-dihydroxyvitamin D3-mediated negative regula-
tion of the human CYP27B1 gene. Nucleic Acids Res 35(8):2734–2747
155. Uitterlinden AG, Fang Y, Van Meurs JB et al (2004) Genetics and biology of vitamin D
receptor polymorphisms. Gene 338(2):143–156
156. van Abel M, Hoenderop JG, Bindels RJ (2005) The epithelial calcium channels TRPV5 and
TRPV6: regulation and implications for disease. Naunyn Schmiedebergs Arch Pharmacol
371(4):295–306
157. van der Schroeff JG, Evers LM, Boot AJ et al (1990) Ras oncogene mutations in basal cell
carcinomas and squamous cell carcinomas of human skin. J Invest Dermatol 94(4):423–425
158. Verheij M, Bose R, Lin XH et al (1996) Requirement for ceramide-initiated SAPK/JNK
signalling in stress-induced apoptosis. Nature 380(6569):75–79
159. Vieth R (1999) Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and
safety. Am J Clin Nutr 69(5):842–856
160. Welsh J (2004) Vitamin D and breast cancer: insights from animal models. Am J Clin Nutr
80(6 Suppl):1721S–1724S
161. Wolpowitz D, Gilchrest BA (2006) The vitamin D questions: how much do you need and
how should you get it? J Am Acad Dermatol 54(2):301–317
162. Wong G, Gupta R, Dixon KM et al (2004) 1, 25-Dihydroxyvitamin D and three low-calce-
mic analogs decrease UV-induced DNA damage via the rapid response pathway. J Steroid
Biochem Mol Biol 89–90(1–5):567–570
163. Xia Z, Dickens M, Raingeaud J et al (1995) Opposing effects of ERK and JNK-p38 MAP
kinases on apoptosis. Science 270(5240):1326–1331
164. Xie Z, Bikle DD (1997) Cloning of the human phospholipase C-gamma1 promoter and iden-
tification of a DR6-type vitamin D-responsive element. J Biol Chem 272(10):6573–6577
165. Xie Z, Bikle DD (1999) Phospholipase C-gamma1 is required for calcium-induced keratino-
cyte differentiation. J Biol Chem 274(29):20421–20424
166. Zehnder D, Bland R, Williams MC et al (2001) Extrarenal expression of 25-hydroxyvitamin
d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 86(2):888–894